AbbVie, Harvard University collaborate for research on emergent viral diseases
AbbVie will provide $30 million over three years
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
TN nodal agency, Guidance to host Pharma & Life Sciences CXO Round Table
Organised in partnership with IDMA and Express Pharma, it will be held on September 3, 2020
Cadila Pharma launches Cadalimab (adalimumab biosimilar) for India
It is used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and psoriasis
Himachal Pradesh raises concerns over bulk drug park evaluation criteria
Reportedly, other hilly, landlocked states share similar concerns
GARDP and Bugworks sign MoU to develop antibiotics for serious bacterial infections
The collaboration includes working together for the preparation of regulatory strategies, in particular for clinical development…
Making India self-sufficient
Dr Gurpreet Sandhu, President, Council for Healthcare and Pharma (CHP) outlines measures to make India self-sufficient in drug and…
Gilead, AstraZeneca and Pfizer may be winners in race for COVID-19 therapeutics and vaccines:…
There is no shortage of candidates to help with COVID-19, but what is lacking right now is data on their efficacy
Active ingredient in insect repellent may protect against COVID-19: UK study
Citriodiol had anti-viral properties if mixed with the virus in the liquid phase and on a test surface
US FDA approves Winlevi, topical acne treatment from Cassiopea
Reportedly, the last FDA approval of an acne drug with a new mechanism of action (MOA) occurred nearly 40 years ago
India’s proposed new agile pharma regulations will benefit innovator companies: GlobalData
This could mean accelerated access of multiple novel therapies and vaccines for Indian patients
DWK Life Sciences acquires Müller + Müller
Müller + Müller will be managed by CEO Florian Müller-Stauch
NPPA to fully automate ecosystem for applications
Also outlines timelines for disposal of received applications
Premas Biotech’s COVID-19 vaccine candidate sees neutralising immune response in animal studies
The company announced that it is in talks with regulatory authorities for human trials of its triple antigen vaccine
Sometimes giants need a shoulder to stand on too
Clarinda Cerejo, VP, Content & Community, CACTUS highlights that it is time to create a more conducive environment for…
Alembic Pharma gets tentative nod from USFDA for Empagliflozin and Linagliptin tablets
Empagliflozin and Linagliptin tablet is indicated as an adjunct to diet and exercise to improve glycemic control in adults with…
Dr Reddy’s Laboratories launches penicillamine capsules in US
It is a chelating agent used in the treatment of Wilson’s disease and to reduce cystine excretion in cystinuria and to treat…
Markets for GvHD in five APAC markets to grow at 8.2 per cent CAGR in 10 years: GlobalData
The impact of approved therapies replacing generic off-label treatments will be the main driver of growth in the 5GM GvHD market
Piramal Pharma Solutions to join hands with Epirium Bio to develop and manufacture orphan drugs
The integrated programme, involving three Piramal Pharma Solutions sites, encompasses formulation development, supply of APIs and…
Moderna informs COVID-19 vaccine induced immune response in older adults in small study
The latest data from an early Phase I study includes an analysis from 20 additional people detailing how the vaccine performed in…
Govt likely to announce short term incentive scheme, excipient makers may get benefit
DoP officials are formulating the guidelines